Click here for a description of the charts and data table
Please tell us if you are using this feature and what you think!
ChEMBL ligand: CHEMBL1110 (A03AE01, Alosetron, Lotronex) |
---|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
DB | Assay description | Assay Type | Standard value | Standard parameter | Original value | Original units | Original parameter | Reference |
---|---|---|---|---|---|---|---|---|
CYP1A2/Cytochrome P450 1A2 in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL3356] [GtoPdb: 1319] [UniProtKB: P05177] | ||||||||
ChEMBL | DRUGMATRIX: CYP450, 1A2 enzyme inhibition (substrate: 3-Cyano-7-ethoxycoumarin) | B | 6.22 | pIC50 | 604.7 | nM | IC50 | DrugMatrix in vitro pharmacology data |
Kv11.1/HERG in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL240] [GtoPdb: 572] [UniProtKB: Q12809] | ||||||||
ChEMBL | Inhibition of human Potassium channel HERG expressed in mammalian cells | B | 5.49 | pIC50 | 3235.94 | nM | IC50 | Bioorg. Med. Chem. Lett. (2003) 13: 2773-2775 [PMID:12873512] |
ChEMBL | Inhibitory concentration against potassium channel HERG | B | 5.49 | pIC50 | 3235.94 | nM | IC50 | Bioorg. Med. Chem. Lett. (2005) 15: 2886-2890 [PMID:15911273] |
ChEMBL | Inhibition of human ERG expressed in CHO cells by whole cell patch clamp technique | B | 5.49 | pIC50 | 3235.94 | nM | IC50 | Bioorg. Med. Chem. (2008) 16: 6252-6260 [PMID:18448342] |
ChEMBL | Inhibition of human ERG channel | B | 5.49 | pIC50 | 3200 | nM | IC50 | J. Med. Chem. (2009) 52: 4266-4276 [PMID:19534531] |
ChEMBL | Inhibition of human ERG channel | B | 5.49 | pIC50 | 3200 | nM | IC50 | J. Med. Chem. (2009) 52: 4266-4276 [PMID:19534531] |
ChEMBL | Inhibition of human ERG expressed in HEK cells by patch clamp technique | B | 5.64 | pIC50 | 2300 | nM | IC50 | Bioorg. Med. Chem. Lett. (2010) 20: 6538-6541 [PMID:20889341] |
5-HT2B receptor/Serotonin 2b (5-HT2b) receptor in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL1833] [GtoPdb: 7] [UniProtKB: P41595] | ||||||||
ChEMBL | DRUGMATRIX: Serotonin (5-Hydroxytryptamine) 5-HT2B radioligand binding (ligand: [3H] Lysergic acid diethylamide) | B | 7.19 | pKi | 64 | nM | Ki | DrugMatrix in vitro pharmacology data |
ChEMBL | DRUGMATRIX: Serotonin (5-Hydroxytryptamine) 5-HT2B radioligand binding (ligand: [3H] Lysergic acid diethylamide) | B | 7 | pIC50 | 100 | nM | IC50 | DrugMatrix in vitro pharmacology data |
5-HT3A/Serotonin 3a (5-HT3a) receptor in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL1899] [GtoPdb: 373] [UniProtKB: P46098] | ||||||||
ChEMBL | Binding affinity to human HT3A receptor | B | 9.3 | pKi | 0.5 | nM | Ki | Bioorg. Med. Chem. Lett. (2010) 20: 6538-6541 [PMID:20889341] |
ChEMBL | Binding affinity to human 5HT3A receptor | B | 9.3 | pKi | 0.5 | nM | Ki | Bioorg. Med. Chem. Lett. (2011) 21: 58-61 [PMID:21146988] |
ChEMBL | Displacement of [9-methyl-3H]BRL-43694 from human 5-HT3A receptor after overnight incubation by scintillation proximity assay | B | 9.3 | pKi | 0.5 | nM | Ki | Bioorg. Med. Chem. Lett. (2014) 24: 2578-2581 [PMID:24755431] |
ChEMBL | Radioligand Binding Assay: The relative affinity of the various compounds for the human 5-HT3 receptor was measured in a radioligand binding assay, using a scintillation proximity assay (SPA) format. Test compounds were dissolved to 10 mM in 100% DMSO, then serially diluted at 10x assay concentrations in 100% DMSO in 96-well polypropylene plates and further diluted to 4x assay concentrations with the assay buffer. Samples were incubated in 50 mM Tris-HCl, pH 7.5, 3 mM MgCl2, 1 mM EDTA and 10% DMSO with 10 nM [9-methyl-3H]BRL-43694 (Perkin Elmer), 3 ug of human 5-HT3 receptor membranes (Perkin Elmer) and 0.5 mg/mL SPA beads (WGA PVT, Amersham Biosciences) in a final volume of 0.2 mL. Binding reactions were set up in wells of PicoPlates-96 (Perkin Elmer) by adding consecutively 50 uL of each competing compound or buffer, SPA beads, the radioligand and 5-HT3 receptor membranes. After an overnight incubation at room temperature on a Nutator mixer, plates were centrifuged for 15 min at 1,500 rpm. | B | 9.3 | pKi | 0.5 | nM | Ki | US-9045501-B2. 5-HT3 receptor modulators, methods of making, and use thereof (2015) |
5-HT3A in Human [GtoPdb: 379] | ||||||||
GtoPdb | - | - | 9.5 | pKi | 0.32 | nM | Ki | J Pharmacol Sci (2007) 104: 263-73 [PMID:17652911] |
ChEMBL data shown on this page come from version 31:
Gaulton A, Hersey A, Nowotka M, Bento AP, Chambers J, Mendez D, Mutowo P, Atkinson F, Bellis LJ, CibriƔn-Uhalte E, Davies M, Dedman N, Karlsson A, MagariƱos MP, Overington JP, Papadatos G, Smit I, Leach AR. (2017) 'The ChEMBL database in 2017.' Nucleic Acids Res., 45(D1). DOI: 10.1093/nar/gkw1074. [PMCID:5210557]